Core Scientific (CORZW) Change in Accured Expenses (2020 - 2026)

Core Scientific has reported Change in Accured Expenses for 7 years, with the latest figure at $171.6 million in Q2 2026.

• Quarterly Change in Accured Expenses rose 151.87% year-over-year to $171.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $67.0 million (down 43.7% YoY) and the FY2025 annual result came in at -$17.4 million, down 1025.53% from the prior year.
• Change in Accured Expenses climbed to $171.6 million in Q2 2026 per CORZW's latest filing, from -$16.4 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $171.6 million in Q2 2026 and troughed at -$45.9 million in Q3 2025.
• A 5-year average of $16.0 million and a median of $2.0 million in 2024 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses soared 1755.99% in 2022, then plunged 3415.53% in 2025.
• Over 5 years, Change in Accured Expenses stood at $17.5 million in 2022, then soared by 571.9% to $117.4 million in 2023, then plunged by 60.17% to $46.8 million in 2024, then tumbled by 190.56% to -$42.3 million in 2025, then soared by 505.21% to $171.6 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $171.6 million, -$16.4 million, and -$42.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.